Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Myositis
•
General Rheumatology
•
Inflammatory arthritis
In patients with anti-PL7 antibody–associated antisynthetase syndrome, can sacroiliitis occur as part of the inflammatory arthritis spectrum, or should alternative causes be considered?
Related Questions
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you approach incidental NXP-2 antibody positivity in patients without current clinical evidence of myositis or systemic autoimmune disease?
How do you guide patients who seek online information about their disease to ensure it is accurate, supports their understanding, and minimizes unnecessary anxiety?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
What strategies do you implement in your clinic to ensure comprehensive screening and timely diagnosis of syphilis in populations with risk factors for sexually transmitted infections?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
Do you recommend genetic screening for FMF in asymptomatic first-degree relatives with a strong family history (multiple family members, severe/refractory disease)?
Would you always pursue excisional biopsy versus core biopsy to confirm Kikuchi's disease?
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
